- Home
- FIVE vs PEN Comparison
FIVE vs PEN Comparison
Compare FIVE & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIVE
- PEN
- Stock Information
- Founded
- FIVE 2002
- PEN 2004
- Country
- FIVE United States
- PEN United States
- Employees
- FIVE N/A
- PEN N/A
- Industry
- FIVE Department/Specialty Retail Stores
- PEN Medical/Dental Instruments
- Sector
- FIVE Consumer Discretionary
- PEN Health Care
- Exchange
- FIVE Nasdaq
- PEN Nasdaq
- Market Cap
- FIVE 8.7B
- PEN 9.7B
- IPO Year
- FIVE 2012
- PEN 2015
- Fundamental
- Price
- FIVE $151.26
- PEN $268.94
- Analyst Decision
- FIVE Buy
- PEN Strong Buy
- Analyst Count
- FIVE 18
- PEN 16
- Target Price
- FIVE $150.29
- PEN $307.19
- AVG Volume (30 Days)
- FIVE 1.1M
- PEN 450.3K
- Earning Date
- FIVE 12-03-2025
- PEN 11-05-2025
- Dividend Yield
- FIVE N/A
- PEN N/A
- EPS Growth
- FIVE N/A
- PEN 367.34
- EPS
- FIVE 4.95
- PEN 4.14
- Revenue
- FIVE $4,231,969,000.00
- PEN $1,333,798,000.00
- Revenue This Year
- FIVE $20.11
- PEN $15.52
- Revenue Next Year
- FIVE $9.88
- PEN $14.20
- P/E Ratio
- FIVE $30.78
- PEN $64.32
- Revenue Growth
- FIVE 13.88
- PEN 14.61
- 52 Week Low
- FIVE $52.38
- PEN $221.26
- 52 Week High
- FIVE $168.98
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- FIVE 46.04
- PEN 62.81
- Support Level
- FIVE $156.50
- PEN $225.52
- Resistance Level
- FIVE $161.99
- PEN $272.00
- Average True Range (ATR)
- FIVE 5.82
- PEN 8.87
- MACD
- FIVE -0.89
- PEN 2.38
- Stochastic Oscillator
- FIVE 26.25
- PEN 93.97
About FIVE Five Below Inc.
Five Below Inc is a specialty value retailer offering merchandise targeted at the tween and teen demographic. The Company's edited assortment of products includes select brands and licensed merchandise. It derives revenue from sales of the Company's merchandise to customers.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.